Development of cabozantinib for the treatment of prostate cancer [Corrigendum]

Overview of attention for article published in Core Evidence, May 2014

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 134 followers.

Development of cabozantinib for the treatment of prostate cancer Corrigendum http://t.co/6hWfIVy1jX

Development of cabozantinib for the treatment of prostate cancer Corrigendum http://t.co/mzMRiPhnEC

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.